Cargando…
Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation
The Lats2 tumor suppressor protein has previously been implicated in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also plays a role in an ATR-Chk1-mediated stress checkpoint in response to oncogenic H-Ras. Activ...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795787/ https://www.ncbi.nlm.nih.gov/pubmed/19855428 http://dx.doi.org/10.1038/onc.2009.270 |
_version_ | 1782175452080635904 |
---|---|
author | Aylon, Yael Yabuta, Norikazu Besserglick, Hila Buganim, Yossi Rotter, Varda Nojima, Hiroshi Oren, Moshe |
author_facet | Aylon, Yael Yabuta, Norikazu Besserglick, Hila Buganim, Yossi Rotter, Varda Nojima, Hiroshi Oren, Moshe |
author_sort | Aylon, Yael |
collection | PubMed |
description | The Lats2 tumor suppressor protein has previously been implicated in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also plays a role in an ATR-Chk1-mediated stress checkpoint in response to oncogenic H-Ras. Activated mutant H-Ras triggers the translocation of Lats2 from centrosomes into the nucleus, coupled with an increase in Lats2 protein levels. This leads to induction of p53 activity, upregulation of proapoptotic genes, downregulation of antiapoptotic genes and eventually apoptotic cell death. Many of the cells that survive apoptosis undergo senescence. However, a fraction of the cells escape this checkpoint mechanism, despite maintaining high mutant H-Ras expression. These escapers display increased genome instability, as evidenced by a substantial fraction of cells with micronuclei and cells with polyploid genomes. Interestingly, such cells exhibit markedly reduced levels of Lats2, in conjunction with enhanced hypermethylation of the Lats2 gene promoter. Our findings suggest that Lats2 might play an important role in quenching H-Ras-induced transformation, while silencing of Lats2 expression might serve as a mechanism to enable tumor progression. |
format | Text |
id | pubmed-2795787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-27957872010-06-17 Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation Aylon, Yael Yabuta, Norikazu Besserglick, Hila Buganim, Yossi Rotter, Varda Nojima, Hiroshi Oren, Moshe Oncogene Article The Lats2 tumor suppressor protein has previously been implicated in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also plays a role in an ATR-Chk1-mediated stress checkpoint in response to oncogenic H-Ras. Activated mutant H-Ras triggers the translocation of Lats2 from centrosomes into the nucleus, coupled with an increase in Lats2 protein levels. This leads to induction of p53 activity, upregulation of proapoptotic genes, downregulation of antiapoptotic genes and eventually apoptotic cell death. Many of the cells that survive apoptosis undergo senescence. However, a fraction of the cells escape this checkpoint mechanism, despite maintaining high mutant H-Ras expression. These escapers display increased genome instability, as evidenced by a substantial fraction of cells with micronuclei and cells with polyploid genomes. Interestingly, such cells exhibit markedly reduced levels of Lats2, in conjunction with enhanced hypermethylation of the Lats2 gene promoter. Our findings suggest that Lats2 might play an important role in quenching H-Ras-induced transformation, while silencing of Lats2 expression might serve as a mechanism to enable tumor progression. 2009-10-26 2009-12-17 /pmc/articles/PMC2795787/ /pubmed/19855428 http://dx.doi.org/10.1038/onc.2009.270 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Aylon, Yael Yabuta, Norikazu Besserglick, Hila Buganim, Yossi Rotter, Varda Nojima, Hiroshi Oren, Moshe Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation |
title | Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation |
title_full | Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation |
title_fullStr | Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation |
title_full_unstemmed | Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation |
title_short | Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation |
title_sort | silencing of the lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant h-ras-driven cell transformation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795787/ https://www.ncbi.nlm.nih.gov/pubmed/19855428 http://dx.doi.org/10.1038/onc.2009.270 |
work_keys_str_mv | AT aylonyael silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation AT yabutanorikazu silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation AT besserglickhila silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation AT buganimyossi silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation AT rottervarda silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation AT nojimahiroshi silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation AT orenmoshe silencingofthelats2tumorsuppressoroverridesap53dependentoncogenicstresscheckpointandenablesmutanthrasdrivencelltransformation |